|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.940 EUR | -1.50% |
|
+2.34% | +84.11% |
| 07-09 | THX Pharma secures its financial roadmap |  |
| 06-23 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors | |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 4 | 4.37 | 4.12 |
| Spread/Res. | -1.50% | -9.84% | -4.37% |
| Spread/Supp. | +9.75% | +84.11% | +48.68% |
| Support | 3.59 | 2.14 | 2.65 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALTHX Stock
- Charts THX Pharma
Select your edition
All financial news and data tailored to specific country editions
